Christina Trojel - Hansen

Christina Trojel-Hansen PhD is the Co-Founder and CEO of CNS2, a company focused on glia-centric capsid evolution and rejuvenation of aging glia. Christina is also involved in various other ventures, including being the Adjunct Assistant Professor at the University of Rochester Medical Center and a Co-Founder of Tune Therapeutics and Pretzel Therapeutics. Christina is dedicated to utilizing the power of the epigenome to treat complex diseases and unlock the potential of regenerative medicine. Additionally, Christina is a Co-Founder of Comorin and Trojel Inc., as well as having experience in companies like ARCH Venture Partners and BioInnovation Institute. Christina's expertise lies in neuro-inflammation and cell therapy for CNS and myelin diseases.